Under the agreement, BevCanna will manufacture Enthusiasmus’s line of Chapeau Noir sparkling cannabis-infused beverages and distribute the products nationally. BevCanna’s experience in formulating and producing a wide range of infused beverage formats makes the Company an ideal fit to manufacture these unique, high-quality beverages. Enthusiasmus will define the product strategy and manage all design, branding and marketing of the new products. The white-label agreement will be subject to minimum order quantities over the term and will drive Canadian cannabis revenue for the Company as it meets the rising demand from prospective brands and partners.
"BevCanna’s core capabilities as a high-capacity beverage manufacturer are an ideal fit for Enthusiasmus’s needs,” said Melise Panetta, President of BevCanna. “By leveraging our unmatched beverage manufacturing capabilities, combined with our coast-to-coast distribution network accessed through our recently announced sales license partnership with Stigma Grow, we’re able to provide a full service solution for our white-label partners and allow them to rapidly penetrate the market.”
“This is the second agreement that we’ve completed in as many days,” Ms. Panetta continued. “We’re very focused on servicing our recently onboarded partners, while also vetting new partners to meet the demand we’re seeing since receipt of our Standard Processing License, and announcing our Sales License partnership. We’re one of the only turn-key beverage manufacturing partners in Canada with the ability to provide an end-to-end solution, and this is both a strong validation of our white-label business model, and a significant contributor to our revenue growth in the Canadian cannabis market.”
“We were seeking a partner with seasoned expertise in producing high-quality beverages, and the capacity to manufacture those beverages at scale,” said Nicholas McCarron CEO and Co-founder of Enthusiasmus Inc. “With the high barriers to entry inherent in the Canadian licensed cannabis industry, BevCanna is unparalleled in its ability to provide the full-service solution that we were looking for, so we’re very pleased to get this deal signed.”
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”
Warren Buffett
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM